Alset Inc. (AEI) · Oct 30, 2026 · Delisting
$1 bid-price deficiency — 180-day cure period ending April 26, 2027
Alset’s Nasdaq deficiency is now formal: the company has 180 days to restore its $1 bid price, with a 1-for-5 reverse split looming.
Alset is a small, diversified holding company built around residential real estate, property development and a portfolio of operating and investment interests, rather than a single high-growth operating business.
The Nasdaq problem is now formal, not hypothetical. The company received notice that its stock had closed below Nasdaq’s $1 minimum bid requirement for 30 consecutive trading days, though the notice does not immediately affect its listing.
The filing creates a clear compliance deadline, but not an immediate delisting event. Alset has until April 26, 2027 to regain compliance by closing at or above $1 for at least 10 consecutive business days; if it fails, it may qualify for another 180-day period, but only if it meets other listing standards and commits to a reverse split. 〔0〕
The main remedy was already telegraphed, so the surprise is limited. Alset had previously announced a 1-for-5 reverse split, and shareholders have already approved that action; this 8-K mainly confirms why the measure is becoming necessary and puts a firm clock around it. The company says it expects to announce the timing shortly. 〔1〕
The filing adds financing and listing pressure without changing the underlying business plan. A reverse split can restore the quoted share price, but it does not by itself improve Alset’s operations, liquidity or market value; failure to cure would escalate the issue toward a delisting determination. 〔2〕
Bottom line: This is a mildly negative compliance update, but mostly the formalization of a problem and remedy the market already knew were developing. The next meaningful step is the announced timing of the 1-for-5 reverse split, not a change to Alset’s operating story.
1-for-5 reverse split timing announcement
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!